hus14

Health Risk Factors
Overweight and Obesity Among Adults
Figure 11. Overweight and obesity among adults aged 20 and over, by
sex: United States, 1988–1994 through 2009–2012
Percent
100
80
60
40
20
Men
Grade 1 obesity
Grade 3 obesity
Grade 2 obesity
Overweight but not obese
Women
Grade 3 obesity
Grade 2 obesity
Grade 1 obesity
Overweight but not obese
0
1988– 1999– 2003– 2009– 1988–
1999– 2003– 2009–
1994 2002 2006 2012 1994
2002 2006 2012
Excel and PowerPoint: http://www.cdc.gov/nchs/hus/contents2014.htm#fig11
Prevention
Influenza and Pneumococcal Vaccination
Between 1988–1994 and 2009–2012, the
prevalence of men and women with Grades 1, 2,
and 3 obesity increased while the prevalence of
men and women aged 20 and over who were
overweight but not obese was stable.
Reducing the prevalence of obesity is a public
health priority because obesity is correlated
with excess morbidity and mortality (14–16). In
particular, Grade 2 or higher obesity (a body
mass index [BMI] of 35 or higher) significantly
increases the risk of death (17). Between
1988–1994 and 2009–2012, the percentage of
adults aged 20 and over with Grade 1 obesity
(BMI greater than or equal to 30 but less than
35), Grade 2 obesity (BMI greater than or equal
to 35 but less than 40), and Grade 3 obesity (BMI
of 40 or higher) increased among both men and
women. During this period, the percentage of
men and women aged 20 and over who were
overweight but not obese (BMI greater than or
equal to 25 but less than 30) was stable. In
2009–2012, 4.4% of men and 8.2% of women
aged 20 and over had Grade 3 obesity.
SOURCE: CDC/NCHS, Health, United States, 2014, Table 64.
Data from the National Health and Nutrition Examination
Survey (NHANES).
During 2003–2013, influenza vaccination in the
past 12 months increased among adults under
age 75, while remaining stable among those aged
75 and over. The percentage of adults aged 65 and
over who had ever received a pneumococcal
vaccination increased during this period.
Vaccination against influenza and invasive
pneumococcal disease is an important public
health strategy (18). During 2003–2013, influenza
vaccination in the past 12 months for
noninstitutionalized adults increased among
those aged 18–49 and 50–74 but was stable
among those aged 75 and over. Decreases in
influenza vaccination coverage in 2005 were
related in part to a vaccine shortage (19).
During 2003–2013, the percentage of noninstitutionalized
adults who had ever received
pneumococcal vaccination was stable among
high-risk persons aged 18–64, and increased
among those aged 65–74 and 75 and over.
NOTE: The pneumococcal high-risk group includes persons
who reported diabetes; cancer; heart, lung, liver, or kidney
disease; or cigarette smoking.
SOURCE: CDC/NCHS, Health, United States, 2014, Tables 74 and
75. Data from the National Health Interview Survey (NHIS).
Figure 12. Influenza and pneumococcal vaccination among noninstitutionalized
adults aged 18 and over, by type of vaccination and age: United States,
2003–2013
Percent
100
80
60
40
20
0
Influenza vaccination in
past 12 months
75 years and over
65–74 years
50–64 years
18–49 years
Pneumococcal vaccination
ever
75 years and over
65–74 years
18–64 years,
high-risk category
2003 2013 2003 2013
Excel and PowerPoint: http://www.cdc.gov/nchs/hus/contents2014.htm#fig12
Health, United States, 2014 Chartbook 15